These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 21262376)

  • 1. Caveolin-3 is a direct molecular partner of the Cav1.1 subunit of the skeletal muscle L-type calcium channel.
    Couchoux H; Bichraoui H; Chouabe C; Altafaj X; Bonvallet R; Allard B; Ronjat M; Berthier C
    Int J Biochem Cell Biol; 2011 May; 43(5):713-20. PubMed ID: 21262376
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Loss of caveolin-3 induced by the dystrophy-associated P104L mutation impairs L-type calcium channel function in mouse skeletal muscle cells.
    Couchoux H; Allard B; Legrand C; Jacquemond V; Berthier C
    J Physiol; 2007 May; 580(Pt.3):745-54. PubMed ID: 17317753
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of the muscular dystrophy-associated caveolin-3(P104L) mutant in adult mouse skeletal muscle specifically alters the Ca(2+) channel function of the dihydropyridine receptor.
    Weiss N; Couchoux H; Legrand C; Berthier C; Allard B; Jacquemond V
    Pflugers Arch; 2008 Nov; 457(2):361-75. PubMed ID: 18509671
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A caveolin-3 mutant that causes limb girdle muscular dystrophy type 1C disrupts Src localization and activity and induces apoptosis in skeletal myotubes.
    Smythe GM; Eby JC; Disatnik MH; Rando TA
    J Cell Sci; 2003 Dec; 116(Pt 23):4739-49. PubMed ID: 14600260
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma membrane removal in rat skeletal muscle fibers reveals caveolin-3 hot-spots at the necks of transverse tubules.
    Murphy RM; Mollica JP; Lamb GD
    Exp Cell Res; 2009 Apr; 315(6):1015-28. PubMed ID: 19101541
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aberrant dysferlin trafficking in cells lacking caveolin or expressing dystrophy mutants of caveolin-3.
    Hernández-Deviez DJ; Martin S; Laval SH; Lo HP; Cooper ST; North KN; Bushby K; Parton RG
    Hum Mol Genet; 2006 Jan; 15(1):129-42. PubMed ID: 16319126
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intracellular localization of dysferlin and its association with the dihydropyridine receptor.
    Ampong BN; Imamura M; Matsumiya T; Yoshida M; Takeda S
    Acta Myol; 2005 Oct; 24(2):134-44. PubMed ID: 16550931
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Muscular atrophy of caveolin-3-deficient mice is rescued by myostatin inhibition.
    Ohsawa Y; Hagiwara H; Nakatani M; Yasue A; Moriyama K; Murakami T; Tsuchida K; Noji S; Sunada Y
    J Clin Invest; 2006 Nov; 116(11):2924-34. PubMed ID: 17039257
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Caveolinopathies: translational implications of caveolin-3 in skeletal and cardiac muscle disorders.
    Gazzerro E; Bonetto A; Minetti C
    Handb Clin Neurol; 2011; 101():135-42. PubMed ID: 21496630
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alterations of excitation-contraction coupling and excitation coupled Ca(2+) entry in human myotubes carrying CAV3 mutations linked to rippling muscle.
    Ullrich ND; Fischer D; Kornblum C; Walter MC; Niggli E; Zorzato F; Treves S
    Hum Mutat; 2011 Mar; 32(3):309-17. PubMed ID: 21294223
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Caveolin-3 deficiency associated with the dystrophy P104L mutation impairs skeletal muscle mitochondrial form and function.
    Shah DS; Nisr RB; Stretton C; Krasteva-Christ G; Hundal HS
    J Cachexia Sarcopenia Muscle; 2020 Jun; 11(3):838-858. PubMed ID: 32090499
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Altered caveolin-3 expression disrupts PI(3) kinase signaling leading to death of cultured muscle cells.
    Smythe GM; Rando TA
    Exp Cell Res; 2006 Sep; 312(15):2816-25. PubMed ID: 16814768
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of a multiprotein complex involved in excitation-transcription coupling of skeletal muscle.
    Arias-Calderón M; Almarza G; Díaz-Vegas A; Contreras-Ferrat A; Valladares D; Casas M; Toledo H; Jaimovich E; Buvinic S
    Skelet Muscle; 2016; 6():15. PubMed ID: 27069569
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Homozygous mutations in caveolin-3 cause a severe form of rippling muscle disease.
    Kubisch C; Schoser BG; von Düring M; Betz RC; Goebel HH; Zahn S; Ehrbrecht A; Aasly J; Schroers A; Popovic N; Lochmüller H; Schröder JM; Brüning T; Malin JP; Fricke B; Meinck HM; Torbergsen T; Engels H; Voss B; Vorgerd M
    Ann Neurol; 2003 Apr; 53(4):512-20. PubMed ID: 12666119
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Caveolin-3 regulates the activity of Ca
    Matsunobe M; Motohashi N; Aoki E; Tominari T; Inada M; Aoki Y
    Am J Physiol Cell Physiol; 2022 Oct; 323(4):C1137-C1148. PubMed ID: 35993515
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The caveolin-3 P104L mutation in LGMD-1C patients inhibits non-insulin-stimulated glucose metabolism and growth but promotes myocyte proliferation.
    Shang L; Chen T; Xian J; Deng Y; Huang Y; Zhao Q; Liang G; Liang Z; Lian F; Wei H; Huang Q
    Cell Biol Int; 2019 Jun; 43(6):669-677. PubMed ID: 30958599
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of insulin response in skeletal muscle cell by caveolin status.
    Oh YS; Cho KA; Ryu SJ; Khil LY; Jun HS; Yoon JW; Park SC
    J Cell Biochem; 2006 Oct; 99(3):747-58. PubMed ID: 16676355
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dysferlin in a hyperCKaemic patient with caveolin 3 mutation and in C2C12 cells after p38 MAP kinase inhibition.
    Capanni C; Sabatelli P; Mattioli E; Ognibene A; Columbaro M; Lattanzi G; Merlini L; Minetti C; Maraldi NM; Squarzoni S
    Exp Mol Med; 2003 Dec; 35(6):538-44. PubMed ID: 14749532
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TRPC1 binds to caveolin-3 and is regulated by Src kinase - role in Duchenne muscular dystrophy.
    Gervásio OL; Whitehead NP; Yeung EW; Phillips WD; Allen DG
    J Cell Sci; 2008 Jul; 121(Pt 13):2246-55. PubMed ID: 18544631
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Caveolin-3 P104L mutation of LGMD-1C leads to disordered glucose metabolism in muscle cells.
    Deng YF; Huang YY; Lu WS; Huang YH; Xian J; Wei HQ; Huang Q
    Biochem Biophys Res Commun; 2017 Apr; 486(2):218-223. PubMed ID: 28232187
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.